AAAAAA

   
Results: 1-9 |
Results: 9
INFLUENCE OF AGE ON TOREMIFENE PHARMACOKINETICS
Authors: SOTANIEMI EA ANTTILA MI
Citation: Ea. Sotaniemi et Mi. Anttila, INFLUENCE OF AGE ON TOREMIFENE PHARMACOKINETICS, Cancer chemotherapy and pharmacology, 40(2), 1997, pp. 185-188
HEPATITIS-A IMPAIRS THE FUNCTION OF HUMAN HEPATIC CYP2A6 IN-VIVO
Authors: PASANEN M RANNALA Z TOOMING A SOTANIEMI EA PELKONEN O RAUTIO A
Citation: M. Pasanen et al., HEPATITIS-A IMPAIRS THE FUNCTION OF HUMAN HEPATIC CYP2A6 IN-VIVO, Toxicology, 123(3), 1997, pp. 177-184
AGE AND CYTOCHROME P450-LINKED DRUG-METABOLISM IN HUMANS - AN ANALYSIS OF 226 SUBJECTS WITH EQUAL HISTOPATHOLOGIC CONDITIONS
Authors: SOTANIEMI EA ARRANTO AJ PELKONEN O PASANEN M
Citation: Ea. Sotaniemi et al., AGE AND CYTOCHROME P450-LINKED DRUG-METABOLISM IN HUMANS - AN ANALYSIS OF 226 SUBJECTS WITH EQUAL HISTOPATHOLOGIC CONDITIONS, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 331-339
AGE AND CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN MAN
Authors: SOTANIEMI EA LUMME P ARVELA P RAUTIO A
Citation: Ea. Sotaniemi et al., AGE AND CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN MAN, Therapie, 51(4), 1996, pp. 363-366
ANTIPYRINE, COUMARIN AND GLIPIZIDE AFFECT N-ACETYLATION MEASURED BY CAFFEINE TEST
Authors: KLEBOVICH I RAUTIO A SALONPAA P ARVELA P PELKONEN O SOTANIEMI EA
Citation: I. Klebovich et al., ANTIPYRINE, COUMARIN AND GLIPIZIDE AFFECT N-ACETYLATION MEASURED BY CAFFEINE TEST, Biomedicine & pharmacotherapy, 49(5), 1995, pp. 225-227
CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN PATIENTS WITH LIVER AND KIDNEY-DISEASES AND EPILEPTIC PATIENTS
Authors: SOTANIEMI EA RAUTIO A BACKSTROM M ARVELA P PELKONEN O
Citation: Ea. Sotaniemi et al., CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN PATIENTS WITH LIVER AND KIDNEY-DISEASES AND EPILEPTIC PATIENTS, British journal of clinical pharmacology, 39(1), 1995, pp. 71-76
GINSENG THERAPY IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS - EFFECTS ON PSYCHOPHYSICAL PERFORMANCE, GLUCOSE HOMEOSTASIS, SERUM LIPIDS, SERUM AMINOTERMINALPROPEPTIDE CONCENTRATION, AND BODY-WEIGHT
Authors: SOTANIEMI EA HAAPAKOSKI E RAUTIO A
Citation: Ea. Sotaniemi et al., GINSENG THERAPY IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS - EFFECTS ON PSYCHOPHYSICAL PERFORMANCE, GLUCOSE HOMEOSTASIS, SERUM LIPIDS, SERUM AMINOTERMINALPROPEPTIDE CONCENTRATION, AND BODY-WEIGHT, Diabetes care, 18(10), 1995, pp. 1373-1375
PHARMACOKINETICS OF THE NOVEL ANTIESTROGENIC AGENT TOREMIFENE IN SUBJECTS WITH ALTERED LIVER AND KIDNEY-FUNCTION
Authors: ANTTILA M LAAKSO S NYLANDEN P SOTANIEMI EA
Citation: M. Anttila et al., PHARMACOKINETICS OF THE NOVEL ANTIESTROGENIC AGENT TOREMIFENE IN SUBJECTS WITH ALTERED LIVER AND KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 628-635
THE PHARMACOKINETICS OF CASODEX ENANTIOMERS IN SUBJECTS WITH IMPAIREDLIVER-FUNCTION
Authors: COCKSHOTT ID SOTANIEMI EA COOPER KJ JONES DC
Citation: Id. Cockshott et al., THE PHARMACOKINETICS OF CASODEX ENANTIOMERS IN SUBJECTS WITH IMPAIREDLIVER-FUNCTION, British journal of clinical pharmacology, 36(4), 1993, pp. 339-343
Risultati: 1-9 |